Prostate Cancer Spain Drug Forecasts and Treatment Analysis to 2020

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • by GBI Research
  • July 2014
  • 72 pages

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, has released its latest research: “Critical Care Therapeutics in Major Developed Markets to ...

Industries: Therapy | Countries: France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World

MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • by VacZine Analytics Group Of Assay Advantage Ltd
  • July 2014
  • 60 pages

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 - 40% and is region/climate dependent. For those patients failing to respond to symptomatic treatments ...

Industries: Therapy | Countries: Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • by GBI Research
  • June 2014
  • 112 pages

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, “Glioblastoma Multiforme Therapeutics ...

Industries: Therapy | Countries: World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant

  • $ 3 500
  • Industry report
  • by GBI Research
  • April 2014
  • 122 pages

Pancreatic Adenocarcinoma Therapeutics in Major Developed Markets to 2019 - Early Stage Pipeline Shows Diversity of Novel Targets though Commercial Impact Remains Distant Summary GBI Research, the leading business intelligence provider, has released its latest research,‘Pancreatic Adenocarcinoma Therapeutics ...

Industries: Therapy | Countries: World, Japan, Canada, Europe, United States, Spain, Italy, France, Germany, United Kingdom, North America

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • April 2014
  • 44 pages

Cytori Therapeutics, Inc. (CYTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses ...

Industries: Therapy | Countries: Spain

Global Hormone Replacement Therapy (HRT) Industry

Global Hormone Replacement Therapy (HRT) Industry

  • $ 4 950
  • Industry report
  • by Global Industry Analysts
  • January 2014
  • 180 pages

This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2012 through 2020. ...

Industries: Therapy | Countries: World, United States, Canada, Europe, United Kingdom, France, Italy, Germany, Spain, North America, Japan

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2011 - 2020)

Acute Lymphocytic/Lymphoblastic Leukemia Therapeutics Market - (Pipeline Forecast & Market Forecast in G8 Countries) (2011 - 2020)

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • December 2013
  • 157 pages

The acute lymphocytic/lymphoblastic leukemia therapeutics market has growth potential as the incidence rate of the disease is increasing all over the globe. The incidence of acute lymphocytic/lymphoblastic leukemia is higher in children from 0 to 14 years than in those aged 15 years and above. However, ...

Industries: Therapy | Countries: Canada, Spain, Italy, France, Germany, Japan, United States, Europe, World, North America

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation

  • $ 3 500
  • Industry report
  • by GBI Research
  • October 2013
  • 90 pages

Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying Therapies and Market Transformation Summary GBI Research has released its pharmaceuticals report, "Alzheimer's Disease Therapeutics Market to 2019 - Early Stage Innovation Points to Disease Modifying ...

Industries: Therapy | Countries: World, Japan, United States, Spain, Italy, France, Germany

Liver Failure - Pipeline Review, H2 2013

Liver Failure - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • by Global Markets Direct
  • July 2013
  • 54 pages

Liver Failure - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Liver Failure - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Liver Failure, complete with latest updates, and special ...

Industries: Therapy | Countries: Spain, World

TiGenix NV - Product Pipeline Review - 2013

TiGenix NV - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • by Global Markets Direct
  • May 2013
  • 52 pages

TiGenix NV - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?TiGenix NV - Product Pipeline Review - 2013? provides data on the TiGenix NV's research and development focus. The report includes information on current developmental pipeline, complete with latest ...

Industries: Therapy | Countries: World, United States, Spain

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.